Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0CA9H
|
|||
Former ID |
DNC008972
|
|||
Drug Name |
N-Benzyl-4-(2-diphenyl)-1-piperazinehexanamide
|
|||
Synonyms |
CHEMBL492871; N-Benzyl-4-(2-diphenyl)-1-piperazinehexanamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H35N3O
|
|||
Canonical SMILES |
C1CN(CCN1CCCCCC(=O)NCC2=CC=CC=C2)C3=CC=CC=C3C4=CC=CC=C4
|
|||
InChI |
1S/C29H35N3O/c33-29(30-24-25-12-4-1-5-13-25)18-8-3-11-19-31-20-22-32(23-21-31)28-17-10-9-16-27(28)26-14-6-2-7-15-26/h1-2,4-7,9-10,12-17H,3,8,11,18-24H2,(H,30,33)
|
|||
InChIKey |
LQFAQQWXFSOOQJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor act... J Med Chem. 2008 Sep 25;51(18):5813-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.